Daily non-political popular news in brief.

Value of drugs for pre-osteoporosis exaggerated

A series of recent scientific publications have exaggerated the benefits and underplayed the harms of drugs to treat pre-osteoporosis or "osteopenia" potentially encouraging treatment in millions of low risk women, warn experts in this week's BMJ.

Read more »

Keywords: value, drugs, pre-osteoporosis, exaggerated, drug, pre, osteoporosis

« Previous | Next »

Similar news on "Value of drugs for pre-osteoporosis exaggerated":

1. Proposed FDA claim recognizes role of key nutrients in dairy in reducing osteoporosis risk
   01-05-2007 · EurekAlert!
   The Food and Drug Administration has proposed an amended health claim that would communicate to consumers the value of foods high in calcium and vitamin D for reducing the risk of osteoporosis. The National Dairy Council (NDC) acknowledges and supports the body of scientific evidence that backs the proposed claim, which indicates that a lifestyle that includes a well-balanced diet with adequate calcium and vitamin D, and physical activity, helps reduce the risk of osteoporosis.
   Similar news · Read more »
   
2. Annals of Internal Medicine tip sheet for March 20, 2007
   03-19-2007 · EurekAlert!
   The following articles are featured in the upcoming Annals of Internal Medicine: "Flexible Use of Drugs with Close Patient Follow-up Can Successfully Control Rheumatoid Arthritis;" "Osteoporosis Drug Strengthens Bones in Men with Prostate Cancer," and "Experts Show Physicians How to Initiate and Carry Through Timely and Effective Discussions about Hospice with Dying Patients."
   Similar news · Read more »
   
3. Gene Signatures Match Cancer And Other Diseases With Potentially Effective Drugs
   09-29-2006 · ScienceDaily
   In one of the most ambitious spinoffs of the human genome project, researchers at Dana-Farber Cancer Institute, Children's Hospital Boston, the Broad Institute of Harvard and MIT, and other collaborating centers have unveiled a new, systematic approach to drug discovery that matches diseases with potential treatments using a universal language based on cells' distinctive gene activity profiles, or "signatures."
   Similar news · Read more »
   
4. Mouse Tests Predict Drug Response In Relapsing Pancreatic Cancer Patients
   10-12-2006 · ScienceDaily
   By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately 'test drive' chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
   Similar news · Read more »
   
5. The Journal of Clinical Pharmacology looks at effects of smoking cessation drug, 'Varenicline'
   10-31-2006 · EurekAlert!
   Smoking is the world's leading cause of premature death. Smokers who quit are able to significantly reduce their risk of premature death and other health issues -- almost completely if they quit by age thirty and by fifty percent if they quit after age fifty. Because it's so difficult to quit smoking, many are turning to smoking cessation drugs, such as varenicline, to help minimize cravings and other withdrawal symptoms.
   Similar news · Read more »
   
6. Women may be able to 'take break' from osteoporosis drug without losing benefit
   12-26-2006 · EurekAlert!
   Most postmenopausal women who took the osteoporosis drug alendronate for 5 years and then stopped did not have an increased risk for nonvertebral fractures in the next 5 years, suggesting the medication has a lasting effect, according to a study in the December 27 issue of JAMA.
   Similar news · Read more »
   
7. Study suggests some drug resistance to influenza B medications
   04-03-2007 · EurekAlert!
   Use of certain common antiviral drugs during a recent influenza B epidemic in Japan showed the development of viruses with partial resistance to the drugs, according to a study in the April 4 issue of JAMA.
   Similar news · Read more »
   
8. Drugs users are increasingly more cautious with needles
   05-14-2007 · EurekAlert!
   Even though HIV can be well treated these days, drug users are still more cautious about using needles than they used to be. That is the conclusion of Colette Smit following her study into 25 years of HIV in the Netherlands.
   Similar news · Read more »
   
9. Nanoparticles hitchhike on red blood cells: a potential new method for drug delivery
   06-27-2007 · EurekAlert!
   Polymeric nanoparticles are excellent carriers for delivering drugs. However, they are quickly removed from the blood, sometimes in minutes, rendering them ineffective in delivering drugs. This study reports that nanoparticles can be forced to remain in circulation by attaching to red blood cells. Prolonged circulation of nanoparticles in the blood may potentially open new opportunities for the treatment of conditions such as cancer and heart disease.
   Similar news · Read more »
   
10. MIT model could predict cells' response to drugs
    07-30-2007 · EurekAlert!
    MIT researchers have developed a model that could predict how cells will respond to targeted drug therapies. Models based on this approach could help doctors make better treatment choices and drug developers identify the ideal compound. In addition, the model could help test the effectiveness of drugs for a wide range of diseases, including cancer, arthirtis, and immune system disorders.
    Similar news · Read more »